Plasma Apelin, Visfatin and Resistin Levels in Patients with First Episode Psychosis and Chronic Schizophrenia

키워드

참고문헌 (48)

1. Abdullah Bolu, "Serum Levels of High Sensitivity C-reactive Protein in Drug-naïve First-episode Psychosis and Acute Exacerbation of Schizophrenia", Clinical Psychopharmacology and Neuroscience, 17(2), pp.244~249 (2019), 대한정신약물학회[DOI]
2. Beumer W, "Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome", Psychoneuroendocrinology, 37, pp.1901~1911 (2012)
3. Strous RD, "Schizophrenia, autoimmunity and immune system dysregulation : a comprehensive model updated and revisited", J Autoimmun, 27, pp.71~80 (2006)
4. Nillni EA, "Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways", J Biol Chem, 275, pp.36124~36133 (2000)
5. Rybakowski F, "Inverse relationship between leptin increase and improvement in depressive symptoms in anorexia nervosa", Neuro Endocrinol Lett, 35, pp.64~67 (2014)
6. Beumer W, "The immune theory of psychiatric diseases : a key role for activated microglia and circulating monocytes", J Leukoc Biol, 92, pp.959~975 (2012)
7. Shelton RC, "Inflammation in depression : is adiposity a cause", Dialogues Clin Neurosci, 13, pp.41~53 (2011)
8. Antoniades C, "Adiponectin : from obesity to cardiovascular disease", Obes Rev, 10, pp.269~279 (2009)
9. Ronti T, "The endocrine function of adipose tissue: an update", Clin Endocrinol (Oxf), 64, pp.355~365 (2006)
10. Tatemoto K, "Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor", Biochem Biophys Res Commun, 251, pp.471~476 (1998)
11. Reaux A, "Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain", J Neurochem, 77, pp.1085~1096 (2001)
12. Filippatos TD, "Increased plasma visfatin levels in subjects with the metabolic syndrome", Eur J Clin Invest, 38, pp.71~72 (2008)
13. Ognjanovic S, "Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes", Am J Obstet Gynecol, 187, pp.1051~1058 (2002)
14. Moschen AR, "Visfatin, an adipocytokine with proinflammatory and immunomodulating properties", J Immunol, 178, pp.1748~1758 (2007)
15. Seden Demirci, "The Serum Levels of Resistin and Its Relationship with Other Proinflammatory Cytokines in Patients with Alzheimer’s Disease", Clinical Psychopharmacology and Neuroscience, 15(1), pp.59~63 (2017), 대한정신약물학회[DOI]
16. Brunetti L, "Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings", Eur J Pharmacol, 372, pp.237~240 (1999)
17. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
18. Guy W, "ECDEU assessment manual for psychopharmacology", US Department of Health and Human Services Publication, 218~222 (1976)
19. O’Carroll AM, "The apelin receptor APJ : journey from an orphan to a multifaceted regulator of homeostasis", J Endocrinol, 219, pp.R13~R35 (2013)
20. Kleinz MJ, "Emerging roles of apelin in biology and medicine", Pharmacol Ther, 107, pp.198~211 (2005)
21. Cheng B, "Neuroprotection of apelin and its signaling pathway", Peptides, 37, pp.171~173 (2012)
22. Lv SY, "Central apelin-13 inhibits food intake via the CRF receptor in mice", Peptides, 33, pp.132~138 (2012)
23. Sunter D, "Intracerebroventricular injection of apelin-13 reduces food intake in the rat", Neurosci Lett, 353, pp.1~4 (2003)
24. Christensen L, "The effect of food intake on mood", Clin Nutr, 20, pp.161~166 (2001)
25. Licinio-Paixao J, "Hyperinsulinemia; a mediator of decreased food intake and weight loss in anorexia nervosa and major depression", Med Hypotheses, 28, pp.125~130 (1989)
26. Kokare DM, "Involvement of alpha-MSH in the social isolation induced anxiety-and depression-like behaviors in rat", Neuropharmacology, 58, pp.1009~1018 (2010)
27. Holsboer F, "The rationale for corticotropin-releasing hormone receptor(CRH-R)antagonists to treat depression and anxiety", J Psychiatr Res, 33, pp.181~214 (1999)
28. Stogner KA, "Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats", Eur J Pharmacol, 387, pp.R9~R10 (2000)
29. Lutter M, "The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress", Nat Neurosci, 11, pp.752~753 (2008)
30. Newson MJF, "The effects of apelin on hypothalamic−pituitary−adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor-and vasopressin-dependent mechanisms", J Endocrinol, 202, pp.123~129 (2009)
31. Zeng XJ, "Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons", Exp Cell Res, 316, pp.1773~1783 (2010)
32. O’Donnell LA, "Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury", J Neurochem, 102, pp.1905~1917 (2007)
33. Kitani T, "Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor", FEBS Lett, 544, pp.74~78 (2003)
34. Samal B, "Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor", Mol Cell Biol, 14, pp.1431~1437 (1994)
35. Lu LF, "Elevated visfatin", pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke, 2009, pp.18, 354~359
36. Zhang W, "Neuronal protective role of PBEF in a mouse model of cerebral ischemia", J Cereb Blood Flow Metab, 30, pp.1962~1971 (2010)
37. Ghaffari MA, "Increased serum levels of tumor necrosis factor-alpha, resistin, and visfatin in the children with autism spectrum disorders : a case-control study", Neurol Res Int, 2016, pp.9060751~ (2016)
38. Dostálová I, "Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa", Physiol Res, 58, pp.903~907 (2009)
39. Ziora K, "Assessment of serum visfatin levels in girls with anorexia nervosa", Clin Endocrinol(Oxf), 76, pp.514~519 (2012)
40. Patel L, "Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators", Biochem Biophys Res Commun, 300, pp.472~476 (2003)
41. Zeugmann S, "Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome", J Clin Psychiatry, 71, pp.1007~1016 (2010)
42. Weber-Hamann B, "Resistin and adiponectin in major depression : the association with free cortisol and effects of antidepressant treatment", J Psychiatr Res, 41, pp.344~350 (2007)
43. Brunetti L, "Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus", Eur J Pharmacol, 493, pp.41~44 (2004)
44. Yumru M, "Serum resistin levels and metabolic changes in bipolar disorder", J Mood Disord, 2, pp.47~50 (2012)
45. Dostalova I, "Adipose tissue resistin levels in patients with anorexia nervosa", Nutrition, 22, pp.977~983 (2006)
46. Rodrigues DH, "Changes in adipokine levels in autism spectrum disorders", Neuropsychobiology, 69, pp.6~10 (2014)
47. Ari M, "Serum adiponectin and resistin levels in patients with obsessive compulsive disorder", J Affect Disord, 136, pp.979~982 (2012)
48. Balõtšev R, "Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients : a 7-month follow-up study", Early Interv Psychiatry, 13, pp.101~109 (2019)

관련 논문AI추천